Interferons and their stimulated genes in the tumor microenvironment

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• Constitutive expression of interferons (IFNs) and their signaling pathways are crucial for host responses against malignant cells within the tumor microenvironment.
• IFNs are induced by the innate immune system and within tumors via Toll-like receptors (TLRs) and cytokine signaling.
• While exogenous IFNs are used in oncology, endogenous IFNs' autocrine and paracrine effects are critical for neoplastic disease outcomes.

Purpose of the Study:

• To elucidate the multifaceted roles of endogenous interferons (IFNs) in the tumor microenvironment.
• To explore how IFN signaling influences tumor cell behavior and immune cell interactions.
• To investigate the prognostic significance of interferon-stimulated gene (ISG) signatures in cancer.

Main Methods:

• Analysis of IFN-induced transcriptional signaling pathways.
• Investigation of STAT1 activation and its downstream gene products.
• Correlation of interferon-stimulated gene (ISG) signatures with immune response and treatment outcomes.

Main Results:

• IFN signaling modulates over 2,000 genes, affecting tumor cell survival, angiogenesis, and the activity of T cells, NK cells, and dendritic cells.
• The interferon-stimulated gene (ISG) signature can serve as a biomarker for immune response.
• A specific ISG subset indicates a poor response to DNA-damaging therapies like radiation.

Conclusions:

• Endogenous IFNs significantly impact cancer emergence, progression, and regression through complex signaling in the tumor microenvironment.
• IFN-driven gene expression plays a dual role, potentially indicating favorable immune responses but also predicting resistance to certain therapies.
• Understanding IFN dynamics is key to optimizing cancer treatment strategies.